Background: Diagnostic delay is a recognized drawback for a correct management of migraine patients. The aim of this study was to investigate the possible relationship among number and type of examinations performed and diagnostic delay in migraine diagnosis. Methods: We enrolled 500 subjects referred to our Headache Center for a migraine without aura. We analyzed the relationship among diagnostic delay, number of examinations performed and performance of each single test by a Cox regression model and an ordinal logistic regression model. Results: Each individual exam increased a diagnostic delay of at least 12 months (p < 0.05, Cox regression model). Brain CT as the first diagnostic approach had a reduced risk of delay of more than 5 years (OR 0.632, 95% CI 0.71-0.56, p < 0.05, ordinal regression model). Conclusions: The number of instrumental examinations seems to significantly influence the diagnostic delay. This aspect contributes to increase health care costs, the risk of pain chronicization and pharmacological treatment misuse.

Keywords:
Migraine without aura, Instrumental investigations, Diagnostic delay, Health service resources
1.
Headache Classification Committee of the International Headache Society: The international classification of headache disorders (2nd edition). Cephalalgia 2004;24:1-160.
2.
Frishberg BM: The utility of neuroimaging in the evaluation of headache in patients with normal neurologic examination. Neurology 1994;44:1191-1197.
3.
Silberstein SD: Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-762.
4.
Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM: Does this patient have a migraine or need neuroimaging? JAMA 2006;296:1274-1283.
5.
Cevoli S, D'Amico D, Martelletti P, Valguarnera F, Del Bene E, De Simone R, Sarchielli P, Narbone M, Testa L, Genco S, Bussone G, Cortelli P: Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia 2009;29:1285-1293.
6.
Dowson AJ: Analysis of the patients attending a specialist UK headache clinic over a 3-year period. Headache 2003;43:14-18.
7.
Viticchi G, Silvestrini M, Falsetti L, Lanciotti C, Cerqua R, Luzzi S, Provinciali L, Bartolini M: Time delay from onset to diagnosis of migraine. Headache 2011;51:232-236.
8.
Viticchi G, Silvestrini M, Falsetti L, Lanciotti C, Cerqua R, Luzzi S, Provinciali L, Bartolini M: The role of instrumental examinations in delayed migraine diagnosis. Neurol Sci 2011;32:143-144.
9.
Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton RB, Scher AI, Steiner T, Zwart JA: The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193-210.
10.
Latinovic R, Gulliford M, Ridsdale L: Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry 2006;77:385-387.
11.
Valade D, Ducros A: Acute headache in the emergency department. Handb Clin Neurol 2010;97:73-181.
12.
Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J: Cost of disorders of the brain in Europe. Eur J Neurol 2005;12:1-27.
13.
Berg J: Economic evidence in migraine and other headaches: a review. Eur J Health Econ 2004;5:S43-S54.
14.
Stewart WF, Bruce C, Manack A, Buse DC, Varon SF, Lipton RB: A case study for calculating employer costs for lost productive time in episodic migraine and chronic migraine: results of the American Migraine Prevalence and Prevention Study. J Occup Environ Med 2011;53:1161-1171.
15.
Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andrée C: The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 2012;19:703-711.
16.
Insinga RP, Ng-Mak DS, Hanson ME: Costs associated with outpatient, emergency room and inpatient care for migraine in the USA. Cephalalgia 2011;31:1570-1575.
17.
Cady RK, Schreiber CP: Sinus headache or migraine? Considerations in making a differential diagnosis. Neurology 2002;58:10-14.
18.
Vincent MB: Cervicogenic headache: a review comparison with migraine, tension-type headache, and whiplash. Curr Pain Headache Rep 2010;14:238-243.
19.
Yu J, Smith KJ, Brixner DI: Cost effectiveness of pharmacotherapy for the prevention of migraine: a Markov model application. CNS Drugs 2010;24:695-712.
20.
Colás R, Munõz P, Temprano R, Gómez C, Pascual J: Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004;62:1338-1342.
21.
Katić BJ, Krause SJ, Tepper SJ, Hu HX, Bigal ME: Adherence to acute migraine medication: what does it mean, why does it matter? Headache 2010;50:117-129.
22.
Lipton RB: Tracing transformation: chronic migraine classification, progression, and epidemiology. Neurology 2009;72:S3-S7.
23.
Munakata J: Economic burden of transformed migraine: results from the American Migraine prevalence and prevention (AMPP) study. Headache 2009;49:498-508.
24.
Edmeads J, Mackell JA: The economic impact of migraine: an analysis of direct and indirect costs. Headache 2002;42:501-509.
25.
Stovner LJ, Andrée C, Eurolight Steering Committee: Impact of headache in Europe: a review for the Eurolight project. J Headache Pain 2008;9:139-146.
26.
Mennini FS, Gitto L, Martelletti P: Improving care through health economics analyses: cost of illness and headache. J Headache Pain 2008;9:199-206.
27.
Bloudek LM, Stokes M, Buse DC, Wilcox TK, Lipton RB, Goadsby PJ, Varon SF, Blumenfeld AM, Katsarava Z, Pascual J, Lanteri-Minet M, Cortelli P, Martelletti P: Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine study (IBMS). J Head Pain 2012;13:361-378.
28.
Evans RW: Diagnostic testing for the evaluation of headaches. Neurol Clin 1996;14:1-26.
29.
Tsushima Y, Endo K: MR imaging in the evaluation of chronic or recurrent headache. Radiology 2005;235:575-579.
30.
Viticchi G, Falsetti L, Silvestrini M, Luzzi S, Provinciali L, Bartolini M: The real usefulness and indication for migraine diagnosis of neurophysiologic evaluation. Neurol Sci 2012;33:161-163.
31.
Swartz RH, Kern RZ: Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 2004;61:1366-1368.
32.
Mitchell CS, Osborn RE, Grosskreutz SR: Computed tomography in the headache patient: is routine evaluation really necessary? Headache 1993;33:82-86.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.